West Pharmaceutical Services, Inc. (WST)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Mar 14, 2025

$230.11

P/E Ratio

34.42

Market Cap

$16.64B

Description
Add to research
View more

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Metrics
Add to research
View more

Overview

  • HQExton, PA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerWST
  • Price$230.11+2.85%

Trading Information

  • Market cap$16.64B
  • Float99.41%
  • Average Daily Volume (1m)1,269,967
  • Average Daily Volume (3m)934,929
  • EPS$6.75

Company

  • Revenue$2.89B
  • Rev growth (1yr)-1.98%
  • Net income$492.70M
  • Gross margin34.65%
  • EBITDA margin25.93%
  • EBITDA$750.00M
  • EV$23.96B
  • EV/Revenue8.28
  • P/E34.42
  • P/S5.86
  • P/B6.20
  • Debt/Equity11.38
Documents
Add to research
View more